Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- AGL -23.5% (guidance), ANGO -18.5% (guidance), FC -4.4%, MTD -4.3% (withdraws Q4 guidance; results will fall short due to unexpected shipping delays), PCRX -1.6%
Other news:
- APLT -27.7% (topline results for ARISE-HF Phase 3 trial of AT-001)
- MPW -20.6% (provides update on Steward Health Care)
- ALLO -20.4% (announces 2024 platform vision to redefine the future of CAR T Led by ALPHA3; also announces partnership with Foresight Diagnostics)
- TBPH -17.1% (announces results from the Phase 4 YUPELRI PIFR-2 study in patients with severe to very severe chronic obstructive pulmonary disease)
- VYGR -15.9% (prices offering of common stock and warrants for gross proceeds of $100 mln)
- CPRX -11.5% (commences $150 mln public offering; subsequent 15% buyback)
- MAXN -1.7% (Revenue Officer Mark Babcock will step down)
- IREN -1.6% (Announces Monthly Investor Update for December 2023; reports Bitcoin mined of 399; 123 BTC mined in calendar year)
- DH -1.6% (continued weakness after 9% lower yesterday after disclosing restructuring plan)
- STRO -1.1% (highlights potential multi-cancer opportunity for Luvelta)